Nexentis Partners with Boltz AI to Advance Drug Discovery through Innovative Target Screening

RT by new: Nexentis has announced a collaboration with Boltz AI to utilize artificial intelligence in screening transporter targets for potential new drug leads. This initial phase will focus on selected solute carrier proteins to identify promising small-molecule candidates.